Trademark: 79303095
Status Date
Tuesday, February 15, 2022
Registration Number
6641521
Registration Date
Tuesday, February 15, 2022
Filing Date
Monday, October 26, 2020
Published for Opposition
Tuesday, August 24, 2021
5 Medical molecular diagnostic test reagents; medical molecular diagnostic test reagents of body substances, such as bone marrow samples, blood samples, and on human or animal tissue; molecular diagnostic test reagents for cancer for medical purposes; medical molecular diagnostic test reagents, inter alia on the basis of microarray technology and sequencing technology; reagents for use in medical genetic testing; reagents for use in medical genetic testing for the measurement of the gene expression profile; reagents for use in medical genetic testing for the measurement of gene aberrations and mutations; clinical diagnostic test reagents for determination of genetic sub-type of a patient; medical prognostic test reagents for testing of bodily fluids for use in disease detection, namely oncology; predictive test reagents, in search of the effectiveness of a medical treatment and/or to select the medical treatment; diagnostic test reagents and preparations for medical or veterinary purposes; chemical preparations, for medical purposes, for the testing of blood and human or animal tissue, including cancer cells; medical diagnostic test strips for tissue-based diagnostics; diagnostic testing materials for medical use, namely oncology; preparations for detecting mutation in human genes for medical purposes
44 Medical analysis services for diagnostic and treatment-decision purposes provided by medical laboratories; medical analysis for diagnostic and treatment-decision purposes provided by medical laboratories using test scores and data for medical or veterinary purposes for others; medical and veterinary information services provided via the internet; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting services; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; medical analysis services for the diagnosis of cancer
42 Research and development of new products for others; biochemical research and development; pharmaceutical research and development; research and development in the field of diagnostic preparations; biological research, clinical research provided via a website and medical research; scientific research for the benefit of the development of molecular diagnostic tests; analysis and evaluation of results from quality control tests of the goods of others to determine conformity with certification standards; molecular diagnostic analysis; investigation and analysis of body substances and molecular diagnostic test scores for the purpose of the development of new biomarkers development and diagnostic testing of treatment methods for scientific research for medical purposes; development and testing services for the certification of quality or standards of molecular diagnostic tests; computer aided diagnostic testing services for others in the field of science and research related thereto; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; research of pharmaceutical preparations in the field of gene therapy; providing information about medical research in the field of diagnostic testing services in the field of skin cancer
Aug 16, 2022
Final Decision Transaction Processed By Ib
Jul 22, 2022
Final Disposition Notice Sent To Ib
Jul 22, 2022
Final Disposition Processed
May 15, 2022
Final Disposition Notice Created, To Be Sent To Ib
Feb 15, 2022
Registered-Principal Register
Jan 2, 2022
Extension Of Time To Oppose Process - Terminated
Sep 23, 2021
Extension Of Time To Oppose Received
Aug 24, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 24, 2021
Published For Opposition
Aug 22, 2021
Notification Processed By Ib
Aug 4, 2021
Notification Of Possible Opposition Sent To Ib
Aug 4, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 4, 2021
Notification Of Notice Of Publication E-Mailed
Jul 16, 2021
Approved For Pub - Principal Register
Jul 9, 2021
Teas/Email Correspondence Entered
Jul 8, 2021
Correspondence Received In Law Office
Jul 8, 2021
Teas Response To Office Action Received
Apr 25, 2021
Refusal Processed By Ib
Apr 8, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Apr 8, 2021
Refusal Processed By Mpu
Apr 1, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Mar 31, 2021
Non-Final Action Written
Mar 26, 2021
Assigned To Examiner
Feb 2, 2021
Application Filing Receipt Mailed
Jan 29, 2021
New Application Office Supplied Data Entered In Tram
Jan 28, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
